CN1218693C - 中药贴膜剂及其制备方法 - Google Patents
中药贴膜剂及其制备方法 Download PDFInfo
- Publication number
- CN1218693C CN1218693C CN 02146525 CN02146525A CN1218693C CN 1218693 C CN1218693 C CN 1218693C CN 02146525 CN02146525 CN 02146525 CN 02146525 A CN02146525 A CN 02146525A CN 1218693 C CN1218693 C CN 1218693C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicated layer
- active ingredient
- pharmaceutically active
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title description 7
- 239000002313 adhesive film Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 77
- 239000000463 material Substances 0.000 claims abstract description 17
- 239000012528 membrane Substances 0.000 claims abstract description 17
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 239000000853 adhesive Substances 0.000 claims abstract description 9
- 230000001070 adhesive effect Effects 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 239000003292 glue Substances 0.000 claims description 13
- 239000004014 plasticizer Substances 0.000 claims description 9
- -1 sorbitol phthalic acid ester Chemical class 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N o-dicarboxybenzene Natural products OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 21
- 201000010099 disease Diseases 0.000 abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 238000011068 loading method Methods 0.000 abstract description 8
- 238000010521 absorption reaction Methods 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 229940126678 chinese medicines Drugs 0.000 abstract description 4
- 230000028327 secretion Effects 0.000 abstract description 3
- 230000001681 protective effect Effects 0.000 abstract description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract 1
- 230000036783 anaphylactic response Effects 0.000 abstract 1
- 208000003455 anaphylaxis Diseases 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 44
- 239000010410 layer Substances 0.000 description 25
- 210000003516 pericardium Anatomy 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229940114124 ferulic acid Drugs 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- 210000004379 membrane Anatomy 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000032630 lymph circulation Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 4
- 241000628997 Flos Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 4
- 235000001785 ferulic acid Nutrition 0.000 description 4
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 4
- 230000037317 transdermal delivery Effects 0.000 description 4
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 3
- 235000003143 Panax notoginseng Nutrition 0.000 description 3
- 241000180649 Panax notoginseng Species 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 241000736148 Styrax Species 0.000 description 3
- 239000004870 Styrax Substances 0.000 description 3
- 235000000126 Styrax benzoin Nutrition 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 235000010603 pastilles Nutrition 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- 241000717739 Boswellia sacra Species 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- 241000218176 Corydalis Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 241001057584 Myrrha Species 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000000155 isotopic effect Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 238000005325 percolation Methods 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 206010031256 Osteomyelitis chronic Diseases 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000000895 extractive distillation Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 210000004220 fundus oculi Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- ZBELDPMWYXDLNY-UHFFFAOYSA-N methyl 9-(4-bromo-2-fluoroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Br)C=C1F ZBELDPMWYXDLNY-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02146525 CN1218693C (zh) | 2002-10-21 | 2002-10-21 | 中药贴膜剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02146525 CN1218693C (zh) | 2002-10-21 | 2002-10-21 | 中药贴膜剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1491642A CN1491642A (zh) | 2004-04-28 |
CN1218693C true CN1218693C (zh) | 2005-09-14 |
Family
ID=34232773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02146525 Expired - Lifetime CN1218693C (zh) | 2002-10-21 | 2002-10-21 | 中药贴膜剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1218693C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813793A (zh) * | 2012-08-10 | 2012-12-12 | 高文英 | 一种治疗冠心病心绞痛的药丸 |
CN103689961A (zh) * | 2012-09-27 | 2014-04-02 | 赵成喜 | 治疗高血压、心脏病的褥子 |
CN105250995B (zh) * | 2013-09-25 | 2018-06-22 | 河南汇博医疗股份有限公司 | 增生性疤痕修复贴膜及其制备方法 |
CN103690520A (zh) * | 2013-12-30 | 2014-04-02 | 沈阳药科大学 | 一种含有单叶细辛挥发油的贴膜剂、制备方法及其医疗用途 |
CN104784627B (zh) * | 2015-02-06 | 2018-05-22 | 肖琼 | 一种用于治疗外科开放性或闭合性损伤的中药外用膜剂及其制备方法 |
CN108434288A (zh) * | 2018-06-18 | 2018-08-24 | 马南行 | 一种用于心脏病预防和治疗的组合物 |
-
2002
- 2002-10-21 CN CN 02146525 patent/CN1218693C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1491642A (zh) | 2004-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110917243B (zh) | 一种含植物提取物的凝胶膏剂及其制备方法 | |
CN1262299C (zh) | 防治冠心病心绞痛的中药贴膜及其制备方法 | |
CN1218693C (zh) | 中药贴膜剂及其制备方法 | |
CN1647803A (zh) | 一种外用消炎镇痛的中药组合物贴膏 | |
CN104274546A (zh) | 一种外用中药组合物、外用中药制剂及其制备方法和应用 | |
CN100502880C (zh) | 一种三七二醇皂苷组合物及其制备方法和用途 | |
CN101564487A (zh) | 一种竭红跌打药剂及其制备方法 | |
CN1583001A (zh) | 红外止咳贴 | |
CN102302616B (zh) | 治疗膝骨性关节炎巴布剂及其制备方法 | |
CN108404095A (zh) | 一种活血通络用于乳腺增生治疗的中药透皮贴剂 | |
CN111956721B (zh) | 一种过敏性鼻炎穴位贴及其制备方法 | |
CN101744873A (zh) | 一种含有独一味环烯醚萜苷的外用液体制剂及其应用 | |
CN110141622B (zh) | 一种治疗疼痛的中药组合物及其制备方法和用途 | |
CN103417941A (zh) | 一种具有抗寒凝血瘀型原发性痛经作用的水凝胶透皮贴剂及其制备方法 | |
CN101711857B (zh) | 一种治疗白脉病的涂膜剂及其制备方法 | |
CN108159114B (zh) | 独一味总环烯醚萜苷提取物、提取方法及其应用 | |
CN101474315B (zh) | 一种祖师麻的有效组分群及其制备方法和应用 | |
CN1903314A (zh) | 治疗头痛,失眠,心悸,乏力的中药组合物及其制备方法 | |
CN110141621B (zh) | 一种治疗疼痛的中药组合物及其制备方法和用途 | |
CN109224004A (zh) | 一种治疗乳腺增生的外用贴剂及其制备方法 | |
CN1201811C (zh) | 一种治疗近视眼的中药组合物及制法 | |
CN102755396A (zh) | 冠心凝胶膏剂制备工艺与基质 | |
CN113730379B (zh) | 一种含白花丹提取物的巴布剂及其制备方法 | |
CN110251638B (zh) | 一种治疗肌筋膜炎的乌青姜发热凝胶膏剂及其制备方法 | |
CN109908297B (zh) | 活血化瘀涂搽药剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING HUAHENGHANFANG PHARMACEUTICAL TECHNOLOGY C Free format text: FORMER OWNER: MA DELIN Effective date: 20090807 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090807 Address after: Room 21, No. 427, torch street, Changping District science and Technology Park, Beijing Patentee after: Beijing Huaheng Hanfang Pharmaceutical Technology Co.,Ltd. Address before: The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, 117 Mei Shan Road, Anhui, Hefei, China Patentee before: Ma Delin |
|
C56 | Change in the name or address of the patentee |
Owner name: BEIJING HUAHENG HANFANG PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: |
|
CP03 | Change of name, title or address |
Address after: 102200, room 219, block B, No. 9, front road, Changping District science and Technology Park, Beijing Patentee after: Beijing Huaheng Hanfang Pharmaceutical Co.,Ltd. Address before: 102200, room 21, 427 torch street, Changping District science and Technology Park, Beijing Patentee before: Beijing Huaheng Hanfang Pharmaceutical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20220810 Address after: 230000 Room 203, building 5, No. 70, Meishan Road, Shushan District, Hefei City, Anhui Province Patentee after: Ma Delin Address before: 102200 room 219, block B, No.9 Chaoqian Road, science and Technology Park, Changping District, Beijing Patentee before: Beijing Huaheng Hanfang Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20050914 |
|
CX01 | Expiry of patent term |